These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 15800924)
1. CYP19 (aromatase) haplotypes and endometrial cancer risk. Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924 [TBL] [Abstract][Full Text] [Related]
2. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475 [TBL] [Abstract][Full Text] [Related]
3. Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women. Straume AH; Knappskog S; Lønning PE J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):69-75. PubMed ID: 21939764 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421 [TBL] [Abstract][Full Text] [Related]
5. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer. Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105 [TBL] [Abstract][Full Text] [Related]
6. [A polymorphism study of the CYP19 gene in endometrial cancer patients]. Bershteĭn LM; Imianitov EN; Suspitsyn EN; Grigor'ev MIu; Sokolov EP; Togo AV; Khanson KP; Poroshina TE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Volkov ON Vopr Onkol; 2000; 46(3):302-5. PubMed ID: 10976276 [TBL] [Abstract][Full Text] [Related]
7. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828 [TBL] [Abstract][Full Text] [Related]
8. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer. Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982 [TBL] [Abstract][Full Text] [Related]
9. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews. Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906 [TBL] [Abstract][Full Text] [Related]
10. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193 [TBL] [Abstract][Full Text] [Related]
11. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Talbott KE; Gammon MD; Kibriya MG; Chen Y; Teitelbaum SL; Long CM; Gurvich I; Santella RM; Ahsan H Breast Cancer Res Treat; 2008 Oct; 111(3):481-7. PubMed ID: 17975727 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study. Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women. Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620 [TBL] [Abstract][Full Text] [Related]
14. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Olson SH; Bandera EV; Orlow I Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639 [TBL] [Abstract][Full Text] [Related]
15. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients. Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches. Olson JE; Ingle JN; Ma CX; Pelleymounter LL; Schaid DJ; Pankratz VS; Vierkant RA; Fredericksen ZS; Wu Y; Couch FJ; Vachon CM; Sellers TA; Weinshilboum RM Breast Cancer Res Treat; 2007 Apr; 102(2):237-47. PubMed ID: 17004113 [TBL] [Abstract][Full Text] [Related]
17. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. Gennari L; Masi L; Merlotti D; Picariello L; Falchetti A; Tanini A; Mavilia C; Del Monte F; Gonnelli S; Lucani B; Gennari C; Brandi ML J Clin Endocrinol Metab; 2004 Jun; 89(6):2803-10. PubMed ID: 15181061 [TBL] [Abstract][Full Text] [Related]
18. Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women. Hosono S; Matsuo K; Ito H; Watanabe M; Hirose K; Nakanishi T; Tajima K; Tanaka H Asian Pac J Cancer Prev; 2011; 12(10):2747-52. PubMed ID: 22320986 [TBL] [Abstract][Full Text] [Related]
19. CYP19 gene polymorphism in endometrial cancer patients. Berstein LM; Imyanitov EN; Suspitsin EN; Grigoriev MY; Sokolov EP; Togo A; Hanson KP; Poroshina TE; Vasiljev DA; Kovalevskij AY; Gamajunova VB J Cancer Res Clin Oncol; 2001 Feb; 127(2):135-8. PubMed ID: 11216915 [TBL] [Abstract][Full Text] [Related]
20. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Baghaei F; Rosmond R; Westberg L; Hellstrand M; Eriksson E; Holm G; Björntorp P Obes Res; 2003 Apr; 11(4):578-85. PubMed ID: 12690088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]